APC	antigen-presenting cell
APM	Antigen presentation machinery
BRCA1	Breast cancer type 1 susceptibility protein
CRT	calreticulin
ccRCC	clear cell renal cell carcinoma
CLIP	class II-associated invariant chain peptide
CRC	colorectal cancer
CTL	cytotoxic T lymphocyte
DAMP	Danger-Associated Molecular Pattern
EMT	Epithelial–Mesenchymal Transition
ER	Endoplasmic reticulum
ERAP	endoplasmic reticulum aminopeptidase protein
EZH2	Enhancer of Zeste Homolog 2
FOXP3	Forkhead Box Protein 3
HCC	hepatocellular carcinoma
HGSC	High-grade serous carcinoma
HLA	human leukocyte antigen
HNPCC	Hereditary Nonpolyposis Colorectal Cancer
HNSCC	head and neck squamous cell carcinoma
ICI	immune checkpoint inhibitor
ICP	immune checkpoint
IFN-γ	interferon-gamma
IRF	Interferon Regulatory Factor
LOH	loss of heterozygosity
MDSC	myeloid-derived suppressor cell
MHC	major histocompatibility complex
mRNA	messenger ribonucleic acid
NBR1	Neighbor of BRCA1 gene 1
NLRC5	NOD-like Receptor C5
NOS2	Nitric oxide synthase 2
NSCLC	Non-small cell lung cancer
OS	Overall survival
PAMP	Pathogen- Associated Molecular Pattern
PD-L1	Programmed Cell Death Ligand 1
PLC	peptide-loading complex
PRC2	Polycomb Repressive Complex 2
RFX5	Regulatory Factor X5
RNS	Reactive nitrogen species
SCC	squamous cell carcinoma
SLO	secondary lymphoid organs
TAA	Tumor-associated antigens
TAP	transporter associated with antigen processing
Tbet	T-box transcription factor TBX21
TCR	T-cell receptor
TEIPP	T cell epitopes associated with impaired peptide processing
TME	Tumor microenvironment
TNF-α	tumor necrosis factor-alpha
TRP1	Tyrosinase-related protein 1
TSA	Tumor-specific antigens
β2m	β2-microglobulin